Search - tctmd.com

Displaying 181 - 200 of 201

$A comparative study between intravenous and intracoronary administration of high doses adenosine for fractional flow reserve measurements, in the “FAME” era.$

Presentation TCT 2012

A comparative study between intravenous and intracoronary administration of high doses adenosine for fractional flow reserve measurements, in the “FAME” era.

Presenter: Jose M. Cubero

January 03, 2012

News Conference News

Adenosine-Free Pressure Measurement Found Equivalent to FFR

L.A. McKeown

December 01, 2011

News Conference News

No LateTIME Benefit for Cell Therapy After Primary PCI

November 14, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Industry News

Instantaneous wave-free ratio, a pressure-only measure of stenosis severity, is comparable to FFR without the use of adenosine

November 10, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Industry News

St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System

October 26, 2011

News Daily News

Meta-analysis: Coronary Collateral Flow Linked to Reduced CAD Mortality

L.A. McKeown

October 07, 2011

News Daily News

IVUS Guidance of DES Implantation Improves Outcomes

September 28, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Industry News

St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System

July 14, 2011

News Daily News

CUPID: Gene Therapy Holds Promise in Heart Failure

July 12, 2011

News Daily News

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

Jason Kahn

June 06, 2011

News Daily News

Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality

L.A. McKeown

May 27, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Conference News

Unique Approach Helps Breach Chronic Total Occlusions in FIM Trial

Jason Kahn

May 18, 2011

News Conference News

PROTECTION-AMI: Experimental Agent Does Not Prevent Reperfusion Injury

Caitlin E. Cox

April 05, 2011

News Daily News

Bone Marrow Stem Cells Show Positive Results in Small Chronic AMI Trial

Jason Kahn

March 17, 2011

News Daily News

Adjunctive Intracoronary Adenosine Lessens No-Reflow in AMI Patients

Jason Kahn

February 27, 2011

Advertisement

A comparative study between intravenous and intracoronary administration of high doses adenosine for fractional flow reserve measurements, in the “FAME” era.

Adenosine-Free Pressure Measurement Found Equivalent to FFR

No LateTIME Benefit for Cell Therapy After Primary PCI

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Instantaneous wave-free ratio, a pressure-only measure of stenosis severity, is comparable to FFR without the use of adenosine

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System

Meta-analysis: Coronary Collateral Flow Linked to Reduced CAD Mortality

IVUS Guidance of DES Implantation Improves Outcomes

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System

CUPID: Gene Therapy Holds Promise in Heart Failure

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

Percutaneous Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Shows Low Mortality

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Unique Approach Helps Breach Chronic Total Occlusions in FIM Trial

PROTECTION-AMI: Experimental Agent Does Not Prevent Reperfusion Injury

Bone Marrow Stem Cells Show Positive Results in Small Chronic AMI Trial

Adjunctive Intracoronary Adenosine Lessens No-Reflow in AMI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content